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Abstract Objectives: To investigate the methods used to
estimate the indirect costs of health-related productivity in
economic evaluations from a company’s perspective.
Methods: The primary literature search was conducted in
Medline and Embase. Supplemental searches were con-
ducted in the Cochrane NHS Economic Evaluation Data-
base, the National Institute for Occupational Safety and
Health database, the Ryerson International Labour, Occu-
pational Safety and Health Index database, scans of refer-
ence lists and researcher’s own literature database. Article
selection was conducted independently by two researchers
based on title, keywords, and abstract, and if needed, full
text. Differences were resolved by a consensus procedure.
Articles were selected based on seven criteria addressing
study population, type of intervention, comparative inter-
vention, outcome, costs, language and perspective, respec-
tively. Characteristics of the measurement and valuation of
health-related productivity were extracted and analyzed
descriptively. Results: A total of 34 studies were included.
Costs of health-related productivity were estimated using
(a combination of) data related to sick leave, compensated
sick leave, light or modiﬁed duty or work presenteeism.
Data were collected from different sources (e.g. adminis-
trative databases, worker self-report, supervisors) and by
different methods (e.g. questionnaires, interviews). Valua-
tion varied in terms of reported time units, composition and
source of the corresponding price weights, and whether
additional elements, such as replacement costs, were
included. Conclusions: Methods for measuring and valuing
health-related productivity vary widely, hindering compa-
rability of results and decision-making. We provide sug-
gestions for improvement.
Keywords Systematic review  Work  Methodology 
Measurement  Valuation  Company
Introduction
Economic evaluations are a tool to help inform decision
makers about how to best allocate limited resources. In
occupational health, the interest in economic evaluations
has steadily grown as stakeholders realize that resources
for occupational health interventions are limited and health
problems in the working population are paired with
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indirect cost of lost productive time by workers with
depression has been estimated to be $44 billion per year
[4], and from a US survey of over 28,000 workers, pro-
ductivity loss costs for companies due to workers’ personal
or family health problems was estimated $226 billion per
year [5]. In The Netherlands, companies are obligated to
continue to pay 70–100% of the salary of employees during
the ﬁrst 2 years of sick leave, regardless of work-related-
ness [6].
For results of economic evaluations to be informative,
they must contain relevant and comparable data on costs
and consequences. The choice of which costs and conse-
quences are included in an economic evaluation is inﬂu-
enced by the perspective taken. Traditionally, a societal
perspective is recommended, and in principle, all costs and
consequences regardless of who pays or gains are included
[7]. However, results from this broad approach may be
difﬁcult to apply for decision making at the local (work-
place) level, warranting evaluations from a more speciﬁc
stakeholder perspective, such as the company [8–10].
Indeed, in addition to growing interest, there is increasing
awareness that company decision makers have a need for
relevant and comparable information so that they can pri-
oritize their budget in order to attain the greatest (health)
gains for their workforce [11, 12].
In economic evaluations conducted from a company’s
perspective, one of the common ways to express the beneﬁt
of occupational health interventions is in terms of health-
related productivity, which are translated into a monetary
value and also referred to as indirect costs [13]. However,
how this key variable is measured and valued may vary
widely. Variability in costing methods used in cost-effec-
tiveness analysis was recently reported by Adams et al.
[14]. While most of the included studies did not include a
measure of productivity, the authors identiﬁed three
potential reasons for the observed variation in how pro-
ductivity is handled: disagreements between existing eco-
nomic evaluation guidelines on whether to include these
costs, lack of practical guidance on how to comply with
recommendations, and a simple omission of this cost in the
guidelines themselves.
Variability in how health-related productivity is mea-
sured and valued can hinder the comparability of studies
addressing the same health problem and across health
problems, thereby limiting the utility of results for deci-
sion-making. In order to identify potential avenues for
standardization, insight into the exact nature of the vari-
ability is needed. Thus, the objective of our systematic
review was to map out the methods used to estimate
indirect costs of health-related productivity in economic
evaluations of occupational health interventions from a
company’s perspective.
Methods
Study Design and Search Strategy
A systematic review was conducted of economic evalua-
tions from a company’s perspective and based on primary
research. We conducted our primary search in EM-
BASE.com, a database that combines all recorded journal
entries of Medline from 1966 and Embase from 1974. An
experienced search specialist from our institute developed
the search strategy (Table 1), which covered the period
from 1966 to April 10, 2007. Supplemental searches were
conducted in the Cochrane NHS Economic Evaluation
Database (NHS EED; search date April 13, 2007), the
National Institute for Occupational Safety and Health
database (NIOSHTIC-2; search date May 1, 2007), and the
Ryerson International Labour, Occupational Safety and
Health Index database (RILOSH; search date May 7,
2007). Additional articles were identiﬁed from reference
lists and the researchers’ own literature databases.
Study Selection
Two reviewers (KU and MdB) independently determined
the eligibility of studies on the basis of title, keywords and
abstract, and if needed, a review of the full text. Differ-
ences in judgement were resolved through a consensus
procedure. We selected studies based on seven criteria:
Table 1 Search strategy in EMBASE.com
Set Search terms
1 (economic-evaluation/exp) AND (employee/exp OR
employee* OR employer/exp OR employer* OR
industrial-worker/exp OR worker* OR work-site OR
worksite OR workman-compensation/de OR
workplace/de OR workplace OR work-capacity/de)
2 Set 1 AND ([cochrane review]/lim OR [controlled
clinical trial]/lim OR [systematic review]/lim OR
comparative-study/de OR intermethod-comparison/de
OR clinical-study/exp OR controlled-study/exp)
3 Set 1 AND (health-program/exp OR health-maintenance-
organization/exp OR occupational-health-service/exp
OR preventive-health-service/exp)
4 Set 1 AND (productivity/exp OR absenteeism/exp OR
return-to-work OR sick-leave OR job-performance/de
OR work-resumption/de)
5 (Measur* OR valuing* OR valuation OR value* OR
signiﬁcance OR analys* OR estimat* OR assess* OR
determinat* OR methodology/de OR accuracy/de)
6 (Set 3 OR set 4) AND set 5
Final set Set 2 OR set 6
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[16 years; (2) the intervention in question was a work-
place or primary care service, technology or program to
prevent work disability; (3) the intervention was compared
to an alternative; (4) an outcome that reﬂected a worker’s
health-related production capacity was measured and val-
ued; (5) at minimum, costs of intervention-related resource
use were included; (6) the study was reported in either
Dutch or English; and (7) the economic analysis was
conducted from a company’s perspective. We excluded
editorials, letters, articles describing the design of eco-
nomic evaluations but not reporting any results, congress
abstracts, reviews and modelling studies.
Data Extraction
To guide our data extraction procedure, we identiﬁed key
aspects of measurement and valuation from existing
guidelines and texts on economic evaluations [7, 15]. With
respect to the measurement, we extracted data on the type
of time losses that were used to quantify health-related
productivity, data collection method and data source used.
With regards to valuation, we extracted data on the time
units and corresponding price weight used, and the com-
position and source of the price weight. In cases where
information could not be found in the articles, we used the
notation, ‘‘not speciﬁed’’. One researcher (KU) extracted
the data and a second researcher (MdB) checked 10% for
accuracy. No disagreements were identiﬁed. We synthe-
sized the data descriptively.
Applied Terminology
We labelled the economic evaluations using the conceptual
matrix proposed by Drummond et al. [7]. The type of
economic evaluation is determined by the number of
alternatives compared, if both costs and consequences are
included, and how the consequences are expressed. In a
cost-effectiveness analysis (CEA), the consequences are
expressed in terms of a unit of effect, such as pain, function
or symptom severity. A cost-utility analysis (CUA) is a
variant in which the unit of effect is quality-adjusted life
years. In a cost-beneﬁt analysis (CBA), all health conse-
quences (i.e. beneﬁts due to improved health, future health
care costs avoided and increased productive output due to
improved health status) are translated into a monetary
value using principles of willingness-to-pay [7]. The label,
ﬁnancial appraisal, was used to denote economic evalua-
tions in which the costs and consequences of two or more
alternatives are compared, but where the monetary conse-
quences were limited to differences in health care use and/
or productivity valued using market prices.
Results
Study Selection
Our primary search in EMBASE.com generated 1,645 hits.
We obtained an additional 166, 477 and 352 hits from
our searches in NHS EED, NIOSHTIC-2 and RILOSH,
respectively. From this total of 2,640 hits, 100 duplicates
were removed, resulting in set of 2,540 articles. Of these,
2,422 were excluded based on title, keywords and abstract,
and the full texts of the remaining 118 articles were
assessed. Thirty studies were included based on our
selection criteria. Thirty of the included studies were
identiﬁed in EMBASE.com, and one from RILOSH. The
searches in NHS EED and NIOSHTIC-2 did not result in
any additional studies. Four additional articles were iden-
tiﬁed from the researchers’ own literature database,
resulting in a total of 34 studies for this review (Fig. 1).
General Description of the Studies
Physical health issues, such as back injury or pain, lacer-
ations and musculoskeletal injuries or pain, were targeted
in half of the studies [16–32]. Six studies evaluated health
promotion/lifestyle and wellness interventions [33–38],
and seven investigated the cost-effectiveness of inﬂuenza
vaccines [39–45]. Mental health problems [46, 47] and
migraine [48, 49] were addressed by two studies each.
The studies originated in eight countries: USA [16, 18, 21,
23–26, 30–33, 36, 38, 39, 42, 46–49], The Netherlands
[17, 20, 28, 35], Canada [19, 27, 37], Australia [34, 40,
45], Sweden [22, 29], Italy [41], Colombia [43], and
Malaysia [44].
Thirty-two studies conducted a ﬁnancial appraisal [16–
34, 36–48], and two studies performed both a ﬁnancial
appraisal and cost-effectiveness analysis [35, 49]. None of
the studies conducted a cost-utility analysis. The lack of
cost-utility analyses may be reﬂective of the fact that
quality-adjusted life years may be considered less relevant
or meaningful as an outcome for company decision makers
compared to health-related productivity. On the cost-side
of the economic evaluations, all studies included costs
related to the programs in the question. Examples of pro-
gram cost items were capital expenditures for equipment,
labour costs for the staff to provide the interventions or run
the programs, and operational, maintenance or material
costs. Eight (24%) studies included the time that employees
take from work to undergo the intervention in the calcu-
lation of the program costs [16, 39–45]. Four studies (12%)
included data on health care use for the health problem,
such as physician contacts, [20, 24, 39, 49]. Proper et al.
[35] included productivity loss costs on the cost-side of the
equation in their cost-effectiveness analysis.
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ﬁnancial appraisals included the monetary value of health-
related productivity. Savings from health care costs were
included by fourteen (41%) analyses [16, 18, 19, 21, 23,
25–27, 30, 32–34, 37, 42]. None of the appraisals included
a monetary valuation of improved health, possibly reﬂec-
tive of the complexity and current debate surrounding the
methodologies such a revealed preference and contingent
valuation [7]. Of the two studies that conducted a cost-
effectiveness analysis, Proper et al. [35] determined the
incremental costs per unit of energy expenditure, sub-
maximal heart rate, proportion meeting the public health
recommendation for physical activity, and upper-extremity
symptoms. Loﬂand et al. [49] analysed costs per disability
day averted. In their economic analysis, Mitchell et al. [24]
considered the difference in total costs per injured worker.
Four studies presented separate data on a health effect such
musculoskeletal pain, discomfort or fatigue [17, 19, 29,
35], function [29], or mental health complaints such as
anxiety, helplessness or depression [29].
Measuring Health-Related Productivity
We identiﬁed four expressions of lost work time that were
used to measure the quantity of health-related productivity:
(1) lost work time due the worker being absent from work
due to a non-compensable health problem; (2) lost time
work that is compensable because it is due to a ‘‘work-
related’’ health problem; (3) lost time work due to workers
being present in the workplace but still unable to perform
all their duties because of incomplete recovery; and (4) lost
time work due to workers are at work in their original
functions, however, perform their tasks less effectively due
to their health problem. To facilitate further reporting, we
used the following four labels to denote each proxy mea-
sure: (1) sick leave; (2) compensated sick leave; (3) limited
or modiﬁed duty; and (4) work-presenteeism.
Absenteeism, whether sick leave or compensated sick
leave, formed the basis of estimates of health-related pro-
ductivity in all of the included studies. Four studies
included both measures [25, 26, 32, 34]. Limited or mod-
iﬁed duty and work-presenteeism were considered by four
[20, 24, 25, 32] and six [17, 43, 44, 46, 48, 49] studies,
respectively.
An overview of data sources for each proxy measure are
presented in Table 2. Data on sick leave was collected
either from administrative databases [20–22, 26, 28, 29,
33–36, 38, 41, 45], self-report [17, 24, 31, 39, 40, 42–44,
46, 48, 49], report by others [16, 22, 25, 32, 47], or else not
speciﬁed [37]. Company databases [20, 21, 26, 28, 33–36,
38, 41, 45] and non-standardized questionnaires [24, 31,
39, 40, 42–44, 46] were the two most commonly used
methods at 32 and 24%, respectively. Of the ten studies
using compensated sick leave to estimate health-related
productivity, data was collected from either the company’s
own workers’ compensation database [23, 25, 30, 32, 34],
that of the insurer [18, 19, 26, 27], or not speciﬁed
[16]. In terms of limited or modiﬁed duty, each of the
four studies [20, 24, 25, 32] collected data in a different
manner. Work-presenteeism was measured by either a
non-standardized [43, 44, 46] or standardized questionnaire
[17, 48, 49].
Reason for exclusions 
￿ Duplicate/overlapping  records  N=100 
￿ Wrong  population/intervention  N=477 
￿ No  comparison  N=1777 
￿ No  work-related  outcome  N=176 
￿  No used resource costs N=21
￿ Language  N=40 
￿ Perspective  N=19
Total # of hits 
N=2640 
EMBASE.COM
# of hits=1645 
NHS EED 
# of hits=166 
RILOSH 
# of hits=477 
NIOSHTIC-2 
# of hits=352 
Researchers’ own 
database N=4
Final set of included 
articles  N=34 
Number of articles included from a 
company’s perspective  N=30 
￿  Embase.com (N=29) 
￿  RILOSH (N=1)
Fig. 1 Selection process
scheme from search results to
through to identiﬁcation of the
ﬁnal set of articles
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Studies that measured health-related productivity by sick
leave, limited or modiﬁed duty or work-presenteeism cal-
culated the costs by using the basic human capital formula:
time lost units * price weight per time unit. Nine of the 10
studies using a measure of compensated sick leave deter-
mined the costs by the actual compensation payments. In
these studies, aggregated totals were reported [16, 18, 19,
23, 25–27, 30, 32]. Monetary award payments from
litigation were included by only one study [30]. The
remaining study using a measure of compensated sick
leave estimated costs via the human capital formula [34].
In the studies valuing sick leave by the human capital
approach, ﬁve sources of variation in the methodology
were observed: the time units used to quantify health-
related productivity; the type of price weight used, the
composition of the price weight, the source of the price
weight, and additional elements in the calculation
(Table 3). First, the time units used to quantify health-
related productivity differed in terms of being either hours
or days. While the majority of studies reported the number
of work days, two additional variations were observed:
accounting for partial days and quantifying calendar
days.
Second, the corresponding price weights varied in terms
of whether a worker-speciﬁc price weight was used, or a
job-speciﬁc, job- and gender-speciﬁc, or generic price
weight. Three studies did not provide information about the
type of price weight [26, 37, 44]. Of the three studies that
used a job-speciﬁc price weight, two used a mean for the
job category [33, 41] and the remaining study did not
include a speciﬁcation [17]. Of the 16 studies that used a
generic price weight, either the mean of the study or
company population was used [20, 31, 35, 36, 38, 42, 43,
45, 46], a national mean [49], a mean from the literature
[29], the median of the study population [47], or not
speciﬁed [28, 39].
Third, the composition of the price weight differed
between studies in terms of whether or not secondary
beneﬁts were included in addition to the wage. Fifteen of
the 28 studies included secondary beneﬁts in their price
weight, six did not and seven studies did not report this
information.
Table 2 Data sources for each
proxy measure of change in
health-related productivity
along with respective references
Data source Description Number of studies [references]
Sick leave
Administrative database Company 11 [20, 21, 26, 28, 33–36, 38, 41, 45]
National Insurance 2 [22, 29]
Self-report Non-standardized questionnaire
(written or telephone)
8[ 24, 31, 39, 40, 42–44, 46]
Standardized questionnaire
(written or telephone)
3[ 17, 48, 49]
Report by others Interview 1 [22]
OSHA log 1 [32]
Monthly injury report or log 3 [16, 25, 47]
Not speciﬁed Method of data collection
not reported
1[ 37]
Compensated sick leave
Administrative database Company 5 [23, 25, 30, 32, 34]
Workers compensation 4 [18, 19, 26, 27]
Limited or modiﬁed duty
Administrative database Company 1 [20]
Self-report Non-standardized questionnaire 1 [24]
Report by others OSHA log 1 [32]
Monthly injury report or log 1 [25]
Work-presenteeism
Self report Non-standardized questionnaire
(written or telephone)
3[ 43, 44, 46]
Standardized questionnaire
(written or telephone)
3[ 17, 48, 49]
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changes measured by sick leave
Valuation
component
Description Number of studies [references]
Time units
Hours Changes in health-related productivity quantiﬁed in hours of work time missed 5 [17, 33, 45–47]
Days Not otherwise speciﬁed: changes in health-related productivity quantiﬁed in days of
work time missed not otherwise speciﬁed. That is, no differentiation was made
between whole and partial days of time loss
20 [21, 22, 24–26, 28, 29, 31,
35–44, 48, 49]
Net or adjusted days: changes in health-related productivity quantiﬁed in which a
differentiation was made between whole and partial days of time loss
3[ 16, 20, 34]
Gross or unadjusted days: although partial days were measured, partial days were
quantiﬁed as whole days of time loss
1[ 20]
Calendar days: changes in health-related productivity quantiﬁed in terms of calendar
days. Note that price weight correspondingly reﬂected a calendar day as opposed to a
work day
2[ 20, 35]
Price weights
Worker-speciﬁc The speciﬁc salary or wage of a worker is used 5 [21, 22, 25, 34, 40]
Job-speciﬁc A uniform price weight is used for all workers in the same job function 3 [17, 33, 41]
Job- and gender-
speciﬁc
A uniform price weight is used for all workers in the same job function but further
differentiated for gender
1[ 48]
Generic One uniform price weight is used with no differentiation for job function, gender or age 16 [16, 20, 24, 28, 29, 31, 35,
36, 38, 39, 42, 43, 45–47, 49]
Not speciﬁed No description of the price weight was provided 3 [26, 37, 44]
Composition of price weights
Wage plus
beneﬁts
The price weight encompasses wages plus secondary beneﬁts 15 [17, 20, 22, 25, 31, 35,
40–47, 49]
Wage only The price weight consisted only of the wage rate 6 [16, 26, 28, 34, 38, 48]
Not speciﬁed No description of the composition was provided 7 [21, 24, 29, 33, 36, 37, 39]
Source of price weight
Company Administrative databases 20 [17, 20–22, 25, 26, 28, 31,
33–36, 38–43, 45, 47]
Literature Published literature 1 [29]
National National databases such as the U.S. Bureau of Labor 2 [48, 49]
Participants Participant self-report 1 [46]
Not speciﬁed Source not speciﬁed 4 [16, 24, 37, 44]
Additional elements
Elasticity This represents the less than proportional decrease in productivity loss to worked hours 1 [35]
Loss of operating
income
This represents the average contribution to the company’s global productivity that is
lost when a worker is absent due to a health problem. This was determined from
company data
3[ 40, 43, 44]
Turnover This represents the costs associated with having to recruit, hire and train a new
employee. It should be noted that there was variation in how these costs were
estimated
2[ 34, 47]
Replacement This represents the costs related to replacing a worker temporarily. The calculation
method of these costs varied or not speciﬁed in each study
3[ 33, 40, 44]
Indirect costs A general rule of thumb of 29 the direct savings were used to account for savings from
‘‘indirect’’ spill over effects such as overtime, turnover, recruiting and training,
increased employee morale and/or non-worker’s compensation related absenteeism
2[ 19, 27]
Wage multipliers These represent weights based on the theoretical model of Pauly et al. that the
productivity loss costs of a worker’s complete absence is more than full wage plus
beneﬁts per day worked
1[ 46]
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weight was obtained from the company. Published litera-
ture, a national database and participant self-report were
the sources of the cost-prices in respectively, one, two and
one study. Four studies did not report the source of their
price weight.
Last, the valuation of sick leave-based productivity
costs differed among the studies in terms of whether or
not additional elements were included in the calculation,
and if included, the type of additional element. Of the 11
studies that included additional elements, one study [35]
adjusted the estimation of sick leave-based productivity
costs based on the assumption of elasticity, which states
that the productivity loss is less than proportional to the
time lost. In contrast, the additional elements considered
in the remaining 10 studies represent extra costs, indi-
cating that productivity loss costs were more than that
based on sick leave time alone [19, 27, 33, 34, 40, 43, 44,
46, 47].
Similar sources of variation were observed in the valu-
ation methodology of limited or modiﬁed duty and work
presenteeism (Table 4).
Table 4 Summary of the time units, price weight characteristics and additional elements used in the valuation of health-related productivity
changes measured by limited or modiﬁed duty and work-presenteeism
Valuation component Description Number of studies [References]
Limited or
modiﬁed duty
Work-presenteeism
Time units
Days Days 3 [24, 25, 32]4 [ 17, 43, 48, 49]
Not speciﬁed Units not speciﬁed 2 [44, 46]
Price weights
Worker-speciﬁc The speciﬁc salary or wage of a worker is used 1 [25]
Job-speciﬁc A uniform price weight is used for all workers in the
same job function
1[ 17]
Job- and gender-speciﬁc A uniform price weight is used for all workers in the
same job function but further differentiated for gender
1[ 48]
Generic One uniform price weight is used with no differentiation
for job function, gender or age
2[ 24, 32]3 [ 43, 46, 49]
Not speciﬁed No description of the price weight was provided 1 [44]
Composition of price weights
Wage plus beneﬁts The price weight encompasses wages plus secondary
beneﬁts. Note that we interpreted the term ‘‘salary’’ to
mean wage plus beneﬁts
1[ 25]5 [ 17, 25, 43, 44, 46, 49]
Wage only The price weight consisted only of the wage rate 1 [48]
Not speciﬁed No description of the composition was provided 2 [24, 32]
Source of price weight
Company Administrative databases 1 [32]3 [ 17, 43, 44]
National National databases such as the U.S. Bureau of Labor 2 [48, 49]
Participants Participant self-report 1 [25]1 [ 46]
Not speciﬁed Source not speciﬁed 1 [24]
Additional elements
Loss of operating income This represents the average contribution to the
company’s global productivity that is lost when a
worker functions less efﬁciently due to a health
problem. This was determined from company data
2[ 43, 44]
Wage multipliers These represent weights based on the theoretical model
of Pauly et al. that the productivity loss costs of a
worker due to work-presenteeism is more than its full
wage equivalent
1[ 46]
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We conducted a systematic review to gain insight into the
variation in how the health-related productivity is mea-
sured and valued in economic evaluations from a com-
pany’s perspective. Thirty-four studies were included. With
respect to measurement, we identiﬁed considerable varia-
tion in the type and number of proxy measures used as well
as the data collection methods for each speciﬁc measure.
With regards to valuation, we observed variation in terms
of the reported time units, type, composition and source of
the unit price weights, and whether additional elements,
such as replacement costs, were included.
To our knowledge, this is the ﬁrst study to systemati-
cally evaluate the variation in how health-related produc-
tivity were measured and valued in economic evaluations
from a company’s perspective. Although we searched four
databases as well as the reference lists of included studies
and our own database, we cannot guarantee that we cap-
tured all eligible studies. We do not believe, however, that
additional studies would signiﬁcantly alter our ﬁndings or
recommendations. Also, given that our searches in NHS
EED and NIOSHTIC-2 did not result in any extra studies,
we conclude that the risk of missed studies is small.
In absence of objective productivity measures, estimates
have been based on lost work time due sick leave. A gold
standard for collecting sick leave data does not exist. Both
databases and questionnaires have their advantages and
disadvantages, which need to be weighed per research
question. However, using insurance databases have a par-
ticular disadvantage in that the data reﬂects what has been
compensated; what has been compensated does not nec-
essarily equate to the actual time a worker has been unable
to work. If lost work time is collected from insurance-
related databases, the amount of time lost during the
waiting period before insurance coverage actually comes
into effect also needed to be measured [50]. Productivity
loss related to sick leave should be supplemented by the
productivity loss due to decreased work performance to
avoid underestimation [51]. For comparability, a stan-
dardized questionnaire should be used. In the past decade
and a half, a number have been developed for this purpose
[52–54]. The fact that very few studies in the review used a
standardized questionnaire may be due to the inevitable
time lag in the knowledge transfer process, even in
research, between new developments and implementation.
Also, time and costs associated with using a standardized
questionnaires may hamper their application.
Valuating health-related productivity into a ﬁnancial
metric makes this variable more interpretable for company
managers. In an economic evaluation, the purpose is to
determine if one intervention is more cost-effective than
another. The productivity loss costs are a main cost driver.
Therefore, it is critical that time units are valued properly.
In particular, one common price weight should be used for
all subjects. This is because the difference in the effect of
the intervention is on the difference in change in produc-
tivity. The use of worker-speciﬁc wages can distort the
actual difference [55]. Currently, there is no gold standard
for valuing health-related productivity. As such, key
assumptions of different methods should be tested in a
sensitivity analysis.
A certain extent of the variation may reﬂect the social
context in which the study takes place. This social context
encompasses political, cultural, legislative and other
aspects such as the type of compensation system, legisla-
tion on workers’ rights for accommodation in the work-
place, or attitudes toward the ability of persons with health
conditions or disability to stay successfully employed.
Studies conducted in countries that have a workers’ com-
pensation system (e.g. Canada and United States) often
used data from workers’ compensation databases. In such
jurisdictions, there is a differentiation between work-rela-
ted and non-work related time loss. In contrast, in countries
such as The Netherlands, such a differentiation does not
exist and all work time loss due to a health problem is
measured as sick leave. Given the variation arising from
context, it is not realistic to think that one exact method for
measurement and valuation can be prescribed. We also
note that social context may inﬂuence the interventions
themselves, that is, interventions may be context speciﬁc,
restricting the extent to which one can learn from cross-
country evidence as well as the results of this current
review. Nevertheless, a future endeavour for the ﬁeld of
occupational health should be to establish best practice
guidelines for economic evaluations of occupational health
interventions. These guidelines should provide explicit
recommendations for reporting key aspects of methodology
underlying the measurement and valuation of health-rela-
ted productivity. Such transparency and improvements in
reporting will simplify the process of determining the
comparability of studies. In addition, it will also facilitate
the transferability of results.
In sum, the variation in the measurement and valuation
methods to determine the indirect costs of health-related
productivity limits comparability of economic evaluations
for the same health problem as well as between health
problems. To help improve the comparability and inter-
pretability of economic evaluations of occupational health
interventions from a company’s perspective, a future
endeavour may be to establish an international task force to
develop standardized guidelines. In the meantime, the
following ﬁve points deserve attention:
(i) Use of standardized questionnaires to measure health-
related productivity.
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time units of health-related productivity. This will
mean disaggregating the amount of work loss from
administrative databases. This may be a challenge
when using workers’ compensation data, however,
just the costs can be misleading as the pay-outs are
dependent on the local jurisdictions and insurance
companies.
(iii) Explicit presentation of the composition and source
of corresponding price weights used to value health-
related productivity.
(iv) Explicit presentation of the additional effects
included in the analysis as well as the rational for
including these effects.
(v) Clear description of the socio-political context in
which the study takes place. This is so that readers
from other jurisdictions can see how the distribution
of burden is similar or different to theirs.
Conclusion
The methods to measure and value health-related produc-
tivity vary widely among economic evaluations of occu-
pational health interventions conducted from a company’s
perspective. This hinders the comparability and usability of
results by occupational health professionals and company
decision makers in order to inform decisions about OH
interventions. We provide suggestions for improvement in
future studies.
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